903 related articles for article (PubMed ID: 26968670)
21. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
22. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL
Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181
[TBL] [Abstract][Full Text] [Related]
23. Antithrombotic treatment in atrial fibrillation.
Lip GY; Boos CJ
Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
[TBL] [Abstract][Full Text] [Related]
24. Concomitant Use of Antiplatelets and Anticoagulants in Patients with Coronary Heart Disease and Atrial Fibrillation: What Do Recent Clinical Trials Teach Us?
Lam DH; Bell SM; Hira RS
Curr Atheroscler Rep; 2018 Jan; 20(1):4. PubMed ID: 29349596
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Web-based education resources informing patients about stroke prevention in atrial fibrillation.
Pandya E; Bajorek BV
J Clin Pharm Ther; 2016 Dec; 41(6):667-676. PubMed ID: 27704588
[TBL] [Abstract][Full Text] [Related]
26. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
27. Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.
Cairns JA; McMurtry MS
Can J Cardiol; 2013 Jul; 29(7 Suppl):S60-70. PubMed ID: 23790600
[TBL] [Abstract][Full Text] [Related]
28. Protecting the brain and the heart: antithrombotic treatment in nonvalvular atrial fibrillation.
Safouris A; Anagnostis P; Karlovasitou A; Karras S; Karagiannis A
Angiology; 2014 May; 65(5):372-8. PubMed ID: 23620311
[TBL] [Abstract][Full Text] [Related]
29. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
Potpara TS; Lip GY
Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
[TBL] [Abstract][Full Text] [Related]
30. Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review.
Alcocer L
Am J Cardiovasc Drugs; 2016 Jun; 16(3):171-82. PubMed ID: 26923792
[TBL] [Abstract][Full Text] [Related]
31. Bleeding risk in patients with atrial fibrillation: the AMADEUS study.
Lane DA; Kamphuisen PW; Minini P; Büller HR; Lip GYH
Chest; 2011 Jul; 140(1):146-155. PubMed ID: 21415134
[TBL] [Abstract][Full Text] [Related]
32. Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project.
Angoulvant D; Villejoubert O; Bejan-Angoulvant T; Ivanes F; Saint Etienne C; Lip GYH; Fauchier L
Chest; 2015 Aug; 148(2):491-498. PubMed ID: 25812113
[TBL] [Abstract][Full Text] [Related]
33. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
34. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
35. Antithrombotic management of atrial fibrillation for stroke prevention in older people.
Tong DC; Albers GW
Clin Geriatr Med; 1999 Nov; 15(4):645-62. PubMed ID: 10499928
[TBL] [Abstract][Full Text] [Related]
36. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
[TBL] [Abstract][Full Text] [Related]
37. What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?
Lip GY
J R Coll Physicians Edinb; 2012; 42 Suppl 18():35-44. PubMed ID: 22518392
[TBL] [Abstract][Full Text] [Related]
38. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
39. Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation.
Cameron C; Coyle D; Richter T; Kelly S; Gauthier K; Steiner S; Carrier M; Coyle K; Bai A; Moulton K; Clifford T; Wells G
BMJ Open; 2014 Jun; 4(6):e004301. PubMed ID: 24889848
[TBL] [Abstract][Full Text] [Related]
40. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.
Huisman MV; Lip GY; Diener HC; Dubner SJ; Halperin JL; Ma CS; Rothman KJ; Teutsch C; Zint K; Ackermann D; Clemens A; Bartels DB
Am Heart J; 2014 Mar; 167(3):329-34. PubMed ID: 24576516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
